BBIO
Alpha Snapshot
BBIO
Technical: AvoidRS rank#488
RS score20.2
Alpha rank#398
Alpha score32.3
Market cap$12.9B
Evidence to review
- Financial data warning: Revenue Source Review
- Financial comparability: Growth comparisons span material statement or share-base changes.
- Financial comparability: Operating profitability improved but remains weak, with a net loss.
- Technical evidence: 50d and 200d breadth have material disagreement; do not collapse them into one risk-on/off read.
- Technical evidence: 20d EMA breadth is early risk-off: 23% above 20d EMA and 71% have two consecutive closes below it.
TechnicalRS Rank
RS score20.2
GroupHealthcare
Group RS83.9
In group9.8
Vs market20.2
Price$66
1M-14.1%
3M-11.7%
6M-11.4%
52w position35.2%
From high-29.6%
Relative volume1.1x
Volume rank70.4%
Close location3.9%
Above 21d: noAbove 50d: noAbove 200d: no50d over 200d: yes
Score Layers
Market8.1Neutral, Mixed
Momentum0.01M -14.1%, 3M -11.7%, 6M -11.4%
Trend1.752w 35.2%, trend 1/4
Demand8.4vol 1.1x, rank 70.4%
Closing strength0.6close 3.9%
Entry quality10.51M -14.1%, from high -29.6%
Drivers
Regime Context8.1
Rs 21d0.0
Rs 63d0.0
Rs 126d0.0
Near 52w High0.0
Trend Structure1.6
Current Demand3.4
Volume Rank 2504.9
AlphaAlpha Rank
TierBelow Average
Fundamental evidence as of2026-09-30
Coverage100.0%
Rankable Universe586
Category Scores
Growth11.3Weak
Quality87.7Strong
Valuation1.7Weak